Vicarious Surgical RBOT
OTC RBOT
$0.04 -0.01 (-17.05%)
At close: Aug 19, 2026 · 3:39 PM UTC

Vicarious Surgical (RBOT) Notes Payables (2020 - 2025)

Vicarious Surgical (RBOT) posted quarterly Notes Payables of $525000.0 for Q4 2025, up 323.39% quarter-over-quarter from $124000.0 in Q2 2020.

Vicarious Surgical (RBOT) Notes Payables (2020 - 2025) Analysis & Trends

Vicarious Surgical (RBOT) has reported Notes Payables for 2 consecutive years, with $525000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Notes Payables changed N/A year-over-year to $525000.0; the TTM figure through Dec 2025 stood at $525000.0 (changed N/A YoY), while the FY2025 annual figure was $525000.0, changed N/A from the prior year.
  • Notes Payables advanced to $525000.0 in Q4 2025 per RBOT's latest filing, from $124000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $525000.0 in Q4 2025 and bottomed at $525000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.19 Bn 194.59 Bn 7.27 Bn
2 Stryker 129.95 Bn 126.47 Bn 4.50 Bn
3 Medtronic 120.06 Bn 110.84 Bn 6.41 Bn
4 Boston Scientific 74.14 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 52.74 Bn 48.49 Bn 1.35 Bn
6 Dexcom 34.60 Bn 32.65 Bn 830.00 Mn
7 GE HealthCare Technologies 34.20 Bn 32.10 Bn 2.18 Bn
8 Koninklijke Philips 26.46 Bn 23.13 Bn 4.55 Bn
9 Steris 23.25 Bn 22.77 Bn 684.20 Mn
10 Vicarious Surgical 196,495.36 -14.84 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 525,000.00
Jun 30, 2020 124,000.00